Topics

Articles

Including patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.

Pharma's Journey with Patient Family Advisory Councils

A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.

Does Patient Priorities Care Result in Better Outcomes for Patients?

As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.

Breaking the Chains of Opioid Addiction: The Promise of Long-Acting Injectables 

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more. 

Cell and Gene Therapy Outlook: Q&A with Fran Gregory, VP of Emerging Therapies, Cardinal Health

Videos

In an interview with Pharma Commerce editor Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses the changing role of PBMs and recent price structure overhauls.

The Evolving Role of PBMs: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

In an interview with  Pharma Commerce editor Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses changes that will come with the pharma giant's new platform.

The Impact of Eli Lilly's New DTC Platform on Rx Drug Sales and Patient Access: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information. 

 P360 Builds Out New Artificial Intelligence-Powered Platform

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.

ixlayer Becomes Member of American Heart Association Center for Health Technology & Innovation Consortium 

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector. 

Patient Support